During the past decade, Medical Oncology and Hematology Associates at John Stoddard Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 68 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 81 trials, followed by "Eastern Cooperative Oncology Group" with 18 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 127 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" are "Breast Cancer" (31 trials), "Lung Cancer" (21 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials), "Lymphoma" (10 trials) and "Melanoma (Skin)" (9 trials). Many other conditions were trialed in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" in a lesser frequency.

Most popular intervention types in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" are "Drug" (104 trials), "Biological" (43 trials), "Other" (40 trials), "Radiation" (24 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (29 trials), "carboplatin" (16 trials), "bevacizumab" (14 trials), "radiation therapy" (14 trials) and "paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" are 106 trials for "All" genders, 17 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology and Hematology Associates at John Stoddard Cancer Center". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 110 completed trials in Medical Oncology and Hematology Associates at John Stoddard Cancer Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology and Hematology Associates at John Stoddard Cancer Center, 5 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".